三博脑科(301293.SZ)：拟与专业投资机构共同投资设立基金

Core Viewpoint - Sanbo Brain Science (301293.SZ) aims to enhance its clinical diagnosis and treatment capabilities by investing in the Tianjin Yuanming Haihe Brain Science Venture Capital Partnership, with a total fundraising target of 300 million yuan, of which the company will contribute 57 million yuan [1] Investment Strategy - The partnership will primarily invest in the brain science sector, focusing on clinical advantages in sub-sectors such as diagnosis, treatment, monitoring, health management, rehabilitation, and medical information technology [1] - The investment strategy emphasizes breakthrough technologies, proprietary intellectual property, and leading-edge brain science enterprises along with their upstream and downstream industry chain [1]